Back to Rankings

LENZ

LENZ TherapeuticsB
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-20
View Chart
+
Peers tracked
10
U.S. public peers
Grade Position
Above peers
vs peer average
LENZ vs peer average
71/100
LENZ vs. peer average (B vs. C)
Grade spread
A 1 · B 3 · D 4 · F 2
Graded peers loaded
Coverage
10 graded
100% of tracked

Peer overview

AUTL is the first available peer comparator.

Autolus: similar small-cap biopharma with active clinical programs and commercialization transition risk; useful operational comparator for trial-to-market cadence.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerAUTLAutolus Therapeutics
LENZ
LENZ Therapeutics
AUTL
Autolus Therapeutics
Grade
B
A
Momentum
2
94
Value
57
41
Sentiment
100
56
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Constructive

Grade position vs AUTL

LENZ / AUTL
Grade Position
Above peers
LENZ vs. peer average (B vs. C)
71/100
Momentum
2
AUTL
Value
57
LENZ
Sentiment
100
LENZ

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs LENZ
1
AUTL
AUTL
B
80/100
Even
2
DSGN
DSGN
B
80/100
Even
3
EQ
Equillium Inc Common
D
40/100
+2
4
IMDX
Insight Molecular Diagnostics Inc Common
F
20/100
+3
5
KZIA
Kazia Therapeutics Ltd ADR
D
40/100
+2
AUTL is the first peer returned for this comparison set.